Proton Therapy for Neuroblastoma: Case Study
Published on
Proton therapy for a 3-year-old with neuroblastoma compared to X-ray therapy allowed a 100-fold reduction in radiation dose to the liver, lungs, and heart.
Published on
Proton therapy for a 3-year-old with neuroblastoma compared to X-ray therapy allowed a 100-fold reduction in radiation dose to the liver, lungs, and heart.
Published on
When he was a child, magician Chad Juros was treated for leukemia at CHOP's Cancer Center. Today, he uses his talents, personal story and message of hope to give back to CHOP.
Published on
The first ever pediatric “Dream Team” dedicated to creating new treatments for childhood cancers will be led CHOP's own John Maris, MD.
Published on
60 Minutes Australia features CHOP’s Stephen Grupp, MD, discussing T cell therapy, how it helped one patient and offers hope for another.
Published on
In the latest report from CHOP’s Cancer Center, we highlight some of the ways our clinicians — and philanthropic partners — are breaking new ground in care and treatment for children with pediatric cancers.
Published on
The New York Times features a story on Emma Whitehead, the first child to receive CTL019, an experimental leukemia treatment.